Home > News

News

Sony Communications International AB v SSH Communications Security Corp16 October 2016 [2016] EWHC 2584 (Pat) Members of Chambers successfully represented Sony in an action dealing with a patent for network communications. The patent in suit was owned by SSH, and related to the use of ‘keepalive’ packets of data when exchanging information between private and public networks through a Network Address Translation (NAT) system. Sony sued […]
Warner Lambert -and- Generics Ltd, Actavis, Caduceus (Pregabalin)13 October 2016Richard Meade QC, Adrian Speck QC and Isabel Jamal appeared for the Respondents, Mylan and Actavis, in this appeal concerning validity and infringement of a Swiss form patent for the use of pregabalin for the treatment of pain. At first instance the Judge had held the patent invalid for insufficiency, since it was not plausible […]
New book: The Liability of Internet Intermediaries, by Jaani Riordan26 September 2016To celebrate the recent publication of the book, Chambers hosted a launch party at Somerset House, London, which was attended by a number of key clients, judges, and academics. The textbook is the first to provide comprehensive analysis of the legal responsibilities of information society services who transmit and host the content of third parties, […]
Actavis and others v ICOS and Lilly [2016] EWHC 1955 (Pat)10 August 2016Members of chambers appeared in this patent action relating to tadalafil, a generic product for treating erectile dysfunction. Actavis, Actelion, Teva and Generics UK (Mylan) sought to “clear the way” in relation to two patents owned by ICOS Corp and of which Eli Lilly and Company were exclusive licencees. Birss J found that EP (UK) […]
Idenix Pharmaceuticals Inc. v Gilead Sciences, Court of Appeal – Awaiting Judgment19 July 2016Andrew Lykiardopoulos QC, Tom Moody-Stuart and William Duncan all acted for Gilead (together with Justin Turner QC) in these patent infringement proceedings brought by Idenix in respect of Gilead’s product “Sovaldi” . The trial was heard over three weeks before Arnold J in 2014, who dismissed Idenix’s claims of patent infringement and held in favour […]